Seagen Inc. (SGEN) earnings
Quarterly and annual SGEN reports and results, each read against the price at its own news timestamp. Back to the SGEN overview →
2 measured SGEN earnings events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Seagen Inc. For: Sep 30 | SEC filing · Form 10-Q | +0.23% | +0.41% | |
| Seagen Third Quarter 2023 Financial Results Reflect Strong Product Sales Growth, and Significant Portfolio and Pipeline Progress | Press release | +0.23% | +0.41% |
Keep exploring
More SGEN: analyst actions → · SEC filings → · SGEN overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| PLANDAI BIOTECHNOLOGY INC (PLPL) | 62 | 0.00% | 41% |
| Biosyent Inc (RX_CDNX) | 62 | 0.00% | 33% |
| THERAPEUTIC SLTNS INTL (TSOI) | 62 | 0.00% | 28% |
| GREEN CURES & BOTANICAL (GRCU) | 61 | 0.00% | 47% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.